Medifast Revenue, Profits - MED Annual Income Statement

Add to My Stocks
$236.31 $12.67 (5.09%) MED stock closing price Sep 17, 2018 (Closing)

MED stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the Medifast stock price. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. The income statement for MED which shows a YOY revenue growth of 9.85% is specific to a period of time. Investors typically check YoY or QoQ revenue growth. Along with Medifast assets and Medifast free cash flow, Medifast profits as shown in profit and loss statement give key insights about the business. The net profit for 2017 is $27.72M and the 2017 revenue is $301.56M.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Medifast Revenues or Net Sales
301.56M274.53M272.77M285.28M356.88M356.7M298.18M257.55M165.61M105.44M
Cost Of Goods Sold (COGS)73.75M68.87M71.45M76.07M89.04M88.67M73.69M65.08M40.29M25.33M
Medifast Gross Profit
227.81M205.66M201.31M209.2M267.84M268.03M224.49M192.46M125.32M80.11M
Research & Development Expense----------
Selling General & Admin Expense188.18M178.8M172.63M178.96M234.25M244.77M197.11M160.82M105.95M71.91M
Income Before Depreciation Depletion Amortization39.63M26.85M28.68M30.24M33.58M23.26M27.38M31.64M19.36M8.19M
Depreciation Depletion Amortization----------
Non Operating Income---1.44M-1.19M----
Interest Expense----------
Medifast Pretax Income
40.32M27.12M29.67M31.69M34.18M24.45M27.68M31.69M19.29M7.85M
Provision for Income Taxes12.6M9.28M10.1M10.66M10.21M8.58M9.13M12.08M7.33M2.41M
MinorityInterest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations27.72M17.83M19.56M21.02M23.96M15.87M18.54M19.61M11.96M5.43M
Extraordinary Items & Discontinued Operations----7.84M------
Medifast Profit/ Loss (Net Income)
27.72M17.83M20.05M13.18M23.96M15.87M18.54M19.61M11.96M5.43M
Average Shares used to compute Diluted EPS12.09M11.95M12.07M12.78M13.82M13.74M14.2M14.57M14.73M14.33M
Average Shares used to compute Basic EPS11.92M11.84M11.96M12.67M13.77M13.72M13.97M14.08M13.52M13.13M
Income Before Nonrecurring Items27.72M22.6M20.94M24.13M23.97M21.6M18.54M19.61M11.96M5.44M
Income from Nonrecurring Items--4.77M-1.37M-3.1M--5.73M----
Medifast Earnings Per Share Basic Net
2.321.511.681.041.741.161.331.390.890.41
Medifast Earnings Per Share Diluted Net
2.291.491.661.031.731.161.311.350.810.38
EPS Diluted Before Nonrecurring Items2.291.891.731.891.731.571.311.350.810.38
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common1.441.070.250.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Medifast stock analysis involves checking at least a few of the important things like:

  • Revenue: The money received by selling of goods or services comes under this line item. A YoY growth - See: Medifast revenue chart implies that the company is growing. It has been the case with Medifast. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. MED stock had a healthy bottom line growth.

The income statement is also called statement of revenue and expense. The MED financials along with Medifast historical stock prices provide a lot of details about the firm.

Medifast Income Statement - Key Financial Ratios

PE Ratio (price earnings ratio)
71.18
PS Ratio (price sales ratio)
7.67
Operating Margin
14.6
Net Profit Margin
12
Dividend Yield
0.74%